163 related articles for article (PubMed ID: 38054839)
21. Germline BAP1 mutations predispose to malignant mesothelioma.
Testa JR; Cheung M; Pei J; Below JE; Tan Y; Sementino E; Cox NJ; Dogan AU; Pass HI; Trusa S; Hesdorffer M; Nasu M; Powers A; Rivera Z; Comertpay S; Tanji M; Gaudino G; Yang H; Carbone M
Nat Genet; 2011 Aug; 43(10):1022-5. PubMed ID: 21874000
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of
Kukuyan AM; Sementino E; Kadariya Y; Menges CW; Cheung M; Tan Y; Cai KQ; Slifker MJ; Peri S; Klein-Szanto AJ; Rauscher FJ; Testa JR
Cancer Res; 2019 Aug; 79(16):4113-4123. PubMed ID: 31151962
[TBL] [Abstract][Full Text] [Related]
23. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.
Joseph NM; Chen YY; Nasr A; Yeh I; Talevich E; Onodera C; Bastian BC; Rabban JT; Garg K; Zaloudek C; Solomon DA
Mod Pathol; 2017 Feb; 30(2):246-254. PubMed ID: 27813512
[TBL] [Abstract][Full Text] [Related]
24. BAP1 GERMLINE MUTATION WITH IRIDOCILIOCHOROIDAL MELANOMA AND MALIGNANT PERITONEAL MESOTHELIOMA.
Yaghy A; Lim LA; Mashayekhi A; Shields CL
Retin Cases Brief Rep; 2022 Mar; 16(2):194-198. PubMed ID: 31895725
[TBL] [Abstract][Full Text] [Related]
25. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.
Carbone M; Ferris LK; Baumann F; Napolitano A; Lum CA; Flores EG; Gaudino G; Powers A; Bryant-Greenwood P; Krausz T; Hyjek E; Tate R; Friedberg J; Weigel T; Pass HI; Yang H
J Transl Med; 2012 Aug; 10():179. PubMed ID: 22935333
[TBL] [Abstract][Full Text] [Related]
26. [Malignant mesothelioma and constitutional BAP1 gene mutations].
Neviere Z; Berthet P; Polycarpe F; Dubos-Arvis C; Dô P; Gervais R
Rev Mal Respir; 2019 Feb; 36(2):241-248. PubMed ID: 30686559
[TBL] [Abstract][Full Text] [Related]
27. Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells.
Hakiri S; Osada H; Ishiguro F; Murakami H; Murakami-Tonami Y; Yokoi K; Sekido Y
Cancer Sci; 2015 Aug; 106(8):990-9. PubMed ID: 26011428
[TBL] [Abstract][Full Text] [Related]
28. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
[TBL] [Abstract][Full Text] [Related]
29. BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma.
Shrestha R; Nabavi N; Lin YY; Mo F; Anderson S; Volik S; Adomat HH; Lin D; Xue H; Dong X; Shukin R; Bell RH; McConeghy B; Haegert A; Brahmbhatt S; Li E; Oo HZ; Hurtado-Coll A; Fazli L; Zhou J; McConnell Y; McCart A; Lowy A; Morin GB; Chen T; Daugaard M; Sahinalp SC; Hach F; Le Bihan S; Gleave ME; Wang Y; Churg A; Collins CC
Genome Med; 2019 Feb; 11(1):8. PubMed ID: 30777124
[TBL] [Abstract][Full Text] [Related]
30. Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal Melanoma.
Kuznetsoff JN; Owens DA; Lopez A; Rodriguez DA; Chee NT; Kurtenbach S; Bilbao D; Roberts ER; Volmar CH; Wahlestedt C; Brothers SP; Harbour JW
Mol Cancer Res; 2021 Feb; 19(2):215-222. PubMed ID: 33077485
[TBL] [Abstract][Full Text] [Related]
31. Targeting BAP1: a new paradigm for mesothelioma.
Schunselaar LM; Zwart W; Baas P
Lung Cancer; 2017 Jul; 109():145-146. PubMed ID: 28342657
[TBL] [Abstract][Full Text] [Related]
32. Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.
Carbone M; Pass HI; Ak G; Alexander HR; Baas P; Baumann F; Blakely AM; Bueno R; Bzura A; Cardillo G; Churpek JE; Dianzani I; De Rienzo A; Emi M; Emri S; Felley-Bosco E; Fennell DA; Flores RM; Grosso F; Hayward NK; Hesdorffer M; Hoang CD; Johansson PA; Kindler HL; Kittaneh M; Krausz T; Mansfield A; Metintas M; Minaai M; Mutti L; Nielsen M; O'Byrne K; Opitz I; Pastorino S; Pentimalli F; de Perrot M; Pritchard A; Ripley RT; Robinson B; Rusch V; Taioli E; Takinishi Y; Tanji M; Tsao AS; Tuncer AM; Walpole S; Wolf A; Yang H; Yoshikawa Y; Zolondick A; Schrump DS; Hassan R
J Thorac Oncol; 2022 Jul; 17(7):873-889. PubMed ID: 35462085
[TBL] [Abstract][Full Text] [Related]
33. Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
Pulford E; Huilgol K; Moffat D; Henderson DW; Klebe S
Dis Markers; 2017; 2017():1310478. PubMed ID: 29085180
[TBL] [Abstract][Full Text] [Related]
34. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
[TBL] [Abstract][Full Text] [Related]
35. BAP1: Not just a BRCA1-associated protein.
Louie BH; Kurzrock R
Cancer Treat Rev; 2020 Nov; 90():102091. PubMed ID: 32877777
[TBL] [Abstract][Full Text] [Related]
36. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
Xu J; Kadariya Y; Cheung M; Pei J; Talarchek J; Sementino E; Tan Y; Menges CW; Cai KQ; Litwin S; Peng H; Karar J; Rauscher FJ; Testa JR
Cancer Res; 2014 Aug; 74(16):4388-97. PubMed ID: 24928783
[TBL] [Abstract][Full Text] [Related]
37. BAP1 protein is a progression factor in malignant pleural mesothelioma.
Arzt L; Quehenberger F; Halbwedl I; Mairinger T; Popper HH
Pathol Oncol Res; 2014 Jan; 20(1):145-51. PubMed ID: 23963927
[TBL] [Abstract][Full Text] [Related]
38. Frequent genomic rearrangements of BRCA1 associated protein-1 (BAP1) gene in Japanese malignant mesothelioma-characterization of deletions at exon level.
Emi M; Yoshikawa Y; Sato C; Sato A; Sato H; Kato T; Tsujimura T; Hasegawa S; Nakano T; Hashimoto-Tamaoki T
J Hum Genet; 2015 Oct; 60(10):647-9. PubMed ID: 26246155
[TBL] [Abstract][Full Text] [Related]
39. Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma.
Sneddon S; Leon JS; Dick IM; Cadby G; Olsen N; Brims F; Allcock RJ; Moses EK; Melton PE; de Klerk N; Musk AW; Robinson BW; Creaney J
Gene; 2015 May; 563(1):103-5. PubMed ID: 25796603
[TBL] [Abstract][Full Text] [Related]
40. Alterations in
Oehl K; Vrugt B; Wagner U; Kirschner MB; Meerang M; Weder W; Felley-Bosco E; Wollscheid B; Bankov K; Demes MC; Opitz I; Wild PJ
Clin Cancer Res; 2021 Apr; 27(8):2277-2291. PubMed ID: 33547197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
